A subsidiary of (Kyowa Hakko Kogyo
Co Ltd) and privately-held (Murex Corp) jointly announced they
signed an agreement giving Kyowa exclusive rights in Japan to
market certain Murex products to detect AIDS.
    The companies estimated that Japanese clinicians will
perform a minimum of 28 mln AIDS tests a year. The Murex
products must be approved by Japanese authorities before they
are sold in Japan.
 Reuter
&#3;